Top Premarket Decliners

MT Newswires Live06-01

Mynd.ai (MYND) shares were down 37% in Monday premarket activity, following Friday's 114.5% gain after the company regained compliance with NYSE American's continued listing requirements.

Zhongchao (ZCMD) stock was down 36%, extending the previous session's 69% decline.

Oculis (OCS) shares were down 32%, adding to the previous session's 23% loss after the company said its OCS-01 eye drops failed to meet the primary endpoint in phase 3 trials in patients with diabetic macular edema.

Aditxt (ADTX) shares were down 30%, extending the previous session's 28.5% decline.

Clearmind Medicine (CMND) stock was down 28%, following the prior session's 46% gain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2640082956?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 19:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640082956","market":"hk","top_or_hot":-1,"title":"Top Premarket Decliners","media":"MT Newswires Live","content":"<html><body><p> Mynd.ai (MYND) shares were down 37% in Monday premarket activity, following Friday's 114.5% gain after the company regained compliance with NYSE American's continued listing requirements.</p><p>Zhongchao (ZCMD) stock was down 36%, extending the previous session's 69% decline.</p><p><a href=\"https://laohu8.com/S/OCS\">Oculis</a> (OCS) shares were down 32%, adding to the previous session's 23% loss after the company said its OCS-01 eye drops failed to meet the primary endpoint in phase 3 trials in patients with diabetic macular edema.</p><p>Aditxt (ADTX) shares were down 30%, extending the previous session's 28.5% decline.</p><p><a href=\"https://laohu8.com/S/CMND\">Clearmind Medicine</a> (CMND) stock was down 28%, following the prior session's 46% gain.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-01 19:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Mynd.ai (MYND) shares were down 37% in Monday premarket activity, following Friday's 114.5% gain after the company regained compliance with NYSE American's continued listing requirements.</p><p>Zhongchao (ZCMD) stock was down 36%, extending the previous session's 69% decline.</p><p><a href=\"https://laohu8.com/S/OCS\">Oculis</a> (OCS) shares were down 32%, adding to the previous session's 23% loss after the company said its OCS-01 eye drops failed to meet the primary endpoint in phase 3 trials in patients with diabetic macular edema.</p><p>Aditxt (ADTX) shares were down 30%, extending the previous session's 28.5% decline.</p><p><a href=\"https://laohu8.com/S/CMND\">Clearmind Medicine</a> (CMND) stock was down 28%, following the prior session's 46% gain.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADTX","symbol_name":"ADiTx Therapeutics","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2640082956","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2640082956","pubTimestamp":1780313798,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mynd.ai (MYND) shares were down 37% in Monday premarket activity, following Friday's 114.5% gain after the company regained compliance with NYSE American's continued listing requirements.Zhongchao (ZC","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADTX":"ADiTx Therapeutics","BK4139":"生物科技","CMND":"Clearmind Medicine, Inc.","BK4204":"教育服务","OCS":"Oculis","ZCMD":"众巢医学","MYND":"Mynd AI","BK4007":"制药"},"translate_title":"盘前跌幅最大的股票","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADTX":1,"MYND":1,"CMND":1,"OCS":1,"ZCMD":1},"content_text":"Mynd.ai (MYND) shares were down 37% in Monday premarket activity, following Friday's 114.5% gain after the company regained compliance with NYSE American's continued listing requirements.Zhongchao (ZCMD) stock was down 36%, extending the previous session's 69% decline.Oculis (OCS) shares were down 32%, adding to the previous session's 23% loss after the company said its OCS-01 eye drops failed to meet the primary endpoint in phase 3 trials in patients with diabetic macular edema.Aditxt (ADTX) shares were down 30%, extending the previous session's 28.5% decline.Clearmind Medicine (CMND) stock was down 28%, following the prior session's 46% gain.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640082956","isCrawlerRequest":true}